 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Myriad Explores NGS Platforms but Cost, Accuracy, and Speed Don't Yet Satisfy Needs for BRCA Testing
August 08, 2012
Myriad Explores NGS Platforms but Cost, Accuracy, and Speed Don't Yet Satisfy Needs for BRCA Testing
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: Myriad's Gary King on Company's New Lab in Germany, European Expansion Strategy
August 8, 2012 / Clinical Sequencing News - Myriad to Launch NGS MyRisk Hereditary Cancer Panel this Year, Replace Existing Tests by Mid-2015
May 15, 2013 / Clinical Sequencing News - Myriad to Replace BRACAnalysis, Other Hereditary Cancer Tests with MyRisk Panel
May 9, 2013 / GenomeWeb Daily News - RainDance Technologies Closes $20M Series E Financing as Myriad Genetics Buys In
April 29, 2013 / GenomeWeb Daily News - Myriad Inks Supply Agreement with RainDance for ThunderStorm Target Enrichment System
April 18, 2013 / GenomeWeb Daily News